HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark R Lackner Selected Research

Mark R Lackner Research Topics

Disease

39Neoplasms (Cancer)
01/2020 - 07/2008
22Breast Neoplasms (Breast Cancer)
01/2020 - 07/2008
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 04/2012
3Disease Progression
01/2020 - 11/2016
3Lung Neoplasms (Lung Cancer)
01/2019 - 12/2011
3Melanoma (Melanoma, Malignant)
01/2018 - 12/2011
3Circulating Neoplastic Cells
04/2012 - 09/2010
2Ovarian Epithelial Carcinoma
07/2015 - 01/2015
2Colorectal Neoplasms (Colorectal Cancer)
04/2014 - 08/2009
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Neoplasm Metastasis (Metastasis)
01/2019
1Adrenal Gland Neoplasms (Adrenal Cancer)
01/2018
1Endometrial Neoplasms (Endometrial Cancer)
11/2016
1Renal Cell Carcinoma (Grawitz Tumor)
10/2016
1Hyperglycemia
10/2016
1Exanthema (Rash)
10/2016
1Hypoxia (Hypoxemia)
10/2016
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2016
1Ovarian Neoplasms (Ovarian Cancer)
07/2015
1Multiple Myeloma
03/2013
1Hematologic Neoplasms (Hematological Malignancy)
03/2013
1Colonic Neoplasms (Colon Cancer)
06/2012
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2011
1Genomic Instability
04/2009
1Neuroblastoma
09/2008

Drug/Important Bio-Agent (IBA)

18Biomarkers (Surrogate Marker)IBA
01/2020 - 07/2008
8Estrogen ReceptorsIBA
01/2020 - 08/2009
8Proteins (Proteins, Gene)FDA Link
10/2016 - 12/2008
7Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2020 - 07/2009
62- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA
12/2017 - 07/2010
6Phenobarbital (Luminal)FDA Link
10/2016 - 07/2008
5Formaldehyde (Formol)FDA Link
01/2019 - 01/2014
5ParaffinIBA
01/2019 - 01/2014
4DNA (Deoxyribonucleic Acid)IBA
01/2019 - 07/2009
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2018 - 07/2009
4Phosphotransferases (Kinase)IBA
01/2012 - 12/2008
3TOR Serine-Threonine KinasesIBA
11/2016 - 12/2011
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
11/2016 - 04/2009
3TensinsIBA
11/2016 - 04/2009
23- (4- (2- (2- chloro- 4- fluorophenyl)- 1- (1H- indazol- 5- yl)but- 1- en- 1- yl)phenyl)acrylic acidIBA
01/2019 - 01/2016
2ErbB Receptors (EGF Receptor)IBA
12/2017 - 06/2011
2Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2017 - 04/2012
2Circulating Tumor DNAIBA
11/2017 - 04/2012
2Progesterone Receptors (Progesterone Receptor)IBA
10/2016 - 11/2014
2RNA (Ribonucleic Acid)IBA
01/2016 - 11/2014
2Docetaxel (Taxotere)FDA Link
10/2015 - 09/2008
2PlatinumIBA
07/2015 - 01/2015
2Messenger RNA (mRNA)IBA
11/2014 - 01/2014
2Class I Phosphatidylinositol 3-KinasesIBA
01/2014 - 07/2010
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
05/2012 - 07/2009
2MitogensIBA
05/2012 - 06/2011
2Protein Kinases (Protein Kinase)IBA
01/2012 - 06/2011
2Insulin-Like PeptidesIBA
05/2010 - 09/2008
2IGF Type 1 Receptor (IGF 1 Receptor)IBA
08/2009 - 09/2008
2Monoclonal AntibodiesIBA
08/2009 - 09/2008
12- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA
01/2020
1Hormones (Hormone)IBA
01/2020
1AndrogensIBA
01/2020
1Cell-Free Nucleic AcidsIBA
01/2019
1VemurafenibIBA
01/2018
1cobimetinibIBA
01/2018
1Tyrosine Kinase InhibitorsIBA
12/2017
1EverolimusFDA Link
10/2016
1human ERBB2 proteinIBA
10/2016
1Mechanistic Target of Rapamycin Complex 1IBA
10/2016
1Anastrozole (Arimidex)FDA LinkGeneric
10/2016
1Fulvestrant (Faslodex)FDA Link
01/2016
1Aromatase InhibitorsIBA
01/2016
1TamoxifenFDA LinkGeneric
01/2016
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2015
1Capecitabine (Xeloda)FDA Link
10/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2015
1PeriostinIBA
07/2015
1Trastuzumab (Herceptin)FDA Link
05/2015
1Ribosomal Proteins (Ribosomal Protein)IBA
01/2015
1Epidermal Growth Factor (EGF)IBA
11/2014
1SolutionsIBA
04/2014
1Matrix Metalloproteinases (MMPs)IBA
04/2014
1ipatasertibIBA
12/2013
1onartuzumabIBA
06/2013
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
06/2013
1Phosphatidylinositols (Phosphatidylinositol)IBA
12/2012
1CateninsIBA
06/2012
1pertuzumabIBA
04/2012
11- (4- ((2- (2- aminopyrimidin- 5- yl)- 7- methyl- 4- morpholinothieno(3,2- d)pyrimidin- 6- yl)methyl)piperazin- 1- yl)- 2- hydroxypropan- 1- oneIBA
12/2011
1MTOR InhibitorsIBA
12/2011
1Transcription Factors (Transcription Factor)IBA
06/2011
1MicroRNAs (MicroRNA)IBA
06/2011
1Epithelial Cell Adhesion MoleculeIBA
09/2010
1Tumor Biomarkers (Tumor Markers)IBA
09/2010
1Estrogen Receptor Modulators (Antiestrogen)IBA
08/2009
1Insulin-Like Growth Factor II (Somatomedin A)IBA
09/2008
1Insulin-Like Growth Factor I (IGF-1)IBA
09/2008
1Glucose (Dextrose)FDA LinkGeneric
09/2008

Therapy/Procedure

10Therapeutics
10/2016 - 07/2009
2Adjuvant Chemotherapy
01/2019 - 01/2016
2Drug Therapy (Chemotherapy)
11/2016 - 07/2015
2Precision Medicine
01/2016 - 04/2014
1Castration
01/2020
1Immunotherapy
01/2019